Treatment

Exosome Therapy

This treatment is used with Dermapen skin needling.

Dp Dermaceuticals™ MG-EXO-SKIN™ serves as the new non-negotiable for in-clinic regenerative procedures. Pioneering the purest exosomes, produced utilising the highest standard CGMP, KFDA, Japan FDA procedures available today. Only MG-EXO-SKIN™ revolutionises aesthetic treatments with dual HylaFuse™ and Calphasome™ delivery systems.  

BIOMIMETIC BLUEPRINT

Replicated from Human Amniotic Fluid Mesenchymal Stem Cell/Trophoblast Cell Exosomes with patented IMMUNE TOLERANT “HLA-G COMPLEXA™ Exosomes do not change the DNA of a cell, they contain the no human DNA. They are not gene therapy.

    • Based on the youngest, most potent, and safest human-compatible source

    • Patented IMMUNE TOLERANT “HLA-G COMPLEXA™” Exosome molecule.

    • Prevents immunity to exosome therapy over time, ensuring results cannot plateau.

    It is also suitable to use as a topical serum post-laser and other professional rejuvenation treatments. However, in a world-first, thanks to its potent active ingredient—Exosomes, Dp Dermaceuticals™ MG-EXO-SKIN™ is a game-changer. Partnering with the Partnering with the awarded and renowned innovators in stem cell research, DermapenWorld™ has sourced ethically produced Exosomes. These are multipotent, highly versatile, the youngest and purest source. The combined therapy allows the regenerative capabilities of Exosomes to accelerate results of microneedling to help improve many skin conditions including sun-damaged, ageing, rosacea and pigmentation. 

    To further maximise the results of in-clinic procedures with MG-EXO-SKIN™, patients are required to continue an at-home skin rejuvenation protocols with Dp Dermaceuticals™ EXO-SKIN™. The non-negotiable dynamic duo delivers an exciting force in regenerative medicine, revolutionising aesthetic procedures, skin health and quality

    • Long term, ongoing results

    • Maximised potential of skin regeneration

    • Boosts natural cellular repair, signals for more youthful looking skin

    • Proven to help reduce the appearance of ageing skin, pigmentation and rosacea

    • Ethically sourced

    • Promotes normalised and youthful regeneration

    • Renews and refreshes for revitalised function

  • Patented IMMUNE TOLERANT “HLA-G COMPLEXA™ Dp Dermaceuticals™ EXOSOME core technology is based on the youngest, most potent, and safest humancompatible source with a patented IMMUNE TOLERANT “HLA-G COMPLEXA™” Exosome molecule. It’s clinically proven to promote an effect that prevents immunity to exosome therapy over time, ensuring results cannot plateau. The more exposure through topical application and in-clinic procedures, the better the results continue, delivering a cumulative effect.

Book your Exosome Therapy